SCHEMBL16615314

SCHEMBL16615314

CN1CCC(c2nc(-c3cc4c(nn3)NCCN4Cc3cc(Cl)ccc3Cl)no2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 5/20 0.47
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
JAK2 O60674 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
NTRK1 P04629 1/20 0.38
LCK P06239 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
IGF1R P08069 1/20 0.38
MET P08581 1/20 0.38
PDGFRB P09619 1/20 0.38
FGFR1 P11362 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
LTK P29376 1/20 0.38
KDR P35968 1/20 0.38
FLT3 P36888 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17918769 0.95 ALK (0.44) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918840 0.89 ALK (0.40) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918694 0.86 ALK (0.49) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918770 0.83 ALK (0.45) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL16615309 0.82 ALK (0.40) ALKJAK2PRKD3MAP4K4ABL1
SCHEMBL16615310 0.82 ALK (0.48) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918772 0.81 PRCP (0.36) SMN1; SMN2ALDH1A1PRCPTSHRHTT
SCHEMBL17918847 0.81 ALK (0.49) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918774 0.81 ALK (0.41) ALKCHEK1AURKAJAK2PRKD3
SCHEMBL17918776 0.80 ALK (0.43) ALKCHEK1AURKAJAK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed